Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Valneva, hit by COVID contract chaos, sees Lyme disease vaccine drop-off in phase 2, but boosters helping
Fierce Biotech
Tue, 09/28/21 - 11:08 am
Tags:
Valneva, Pfizer, Lyme disease, clinical trials, vaccines, VLA15
Pfizer stumbles close to finish line in growth hormone race, extending the lead of rival Ascendis
Fierce Biotech
Mon, 09/27/21 - 10:51 am
Tags:
Pfizer, growth hormone deficiency, FDA, Ascendis Pharma
Merck will pay royalties on next-gen pneumococcal shot to settle Pfizer patent fight
Fierce Pharma
Fri, 09/24/21 - 11:58 am
Tags:
Merck, Pfizer, FDA, vaccines, pneumococcal disease, patents
CDC panel clears way for Pfizer booster shots, but divided on broader use
BioPharma Dive
Thu, 09/23/21 - 10:57 pm
Tags:
CDC, vaccines, COVID-19, Pfizer, BioNTech, boosters
Recall report: Pfizer pulls even more Chantix lots as nitrosamine contamination worries grow
Endpoints
Thu, 09/23/21 - 11:05 am
Tags:
Pfizer, product recalls, Chantix, smoking cessation
Pfizer CEO Bourla asks employees to join the scrum for D.C. drug-pricing fight
Fierce Pharma
Thu, 09/23/21 - 11:03 am
Tags:
Pfizer, drug pricing, Albert Bourla, Pharma CEOs, legislation
FDA green lights booster dose of Pfizer vaccine for older, more vulnerable Americans
BioPharma Dive
Wed, 09/22/21 - 11:38 pm
Tags:
FDA, Pfizer, COVID-19, boosters, Emergency Use Authorization
Who should get Pfizer booster shots? Why? A panel of the C.D.C. is trying to sort it out.
NY Times, NY
Wed, 09/22/21 - 11:25 pm
Tags:
Pfizer, COVID-19, vaccines, boosters, CDC
Pfizer, Moderna, AZ and other COVID vaccine companies face urgent calls to ramp up access around the world
Fierce Pharma
Wed, 09/22/21 - 11:59 am
Tags:
vaccines, COVID-19, Amnesty International, AstraZeneca, BioNTech, JNJ, Moderna Therapeutics, Novavax, Pfizer, intellectual property
Pfizer Covid-19 vaccine generates robust antibody response in children, without serious safety issues, company says
Stat
Mon, 09/20/21 - 12:01 pm
Tags:
Pfizer, BioNTech, COVID-19, pediatric, clinical trials
ESMO: Syros targets KRAS-mutant cancer as CDK7 inhibitor shows early promise
Fierce Biotech
Mon, 09/20/21 - 12:00 pm
Tags:
ESMO, Syros Pharmaceuticals, breast cancer, Pfizer, Ibrance
Bankrolled by Pfizer and Bayer, Pyxis files for $100M IPO to take cancer drugs into the clinic
Fierce Pharma
Mon, 09/20/21 - 11:17 am
Tags:
Pyxis Oncology, IPOs, Pfizer, Bayer
Could Pfizer and Merck Be Big Winners With COVID Pills?
Motley Fool
Mon, 09/20/21 - 12:02 am
Tags:
Pfizer, Merck, drug development, COVID-19
ESMO: Pfizer, Astellas' latest Xtandi survival data may shore up prostate cancer lead over J&J
Fierce Pharma
Sat, 09/18/21 - 08:25 pm
Tags:
ESMO, Pfizer, Astellas, Xtandi, prostate cancer, clinical trials
Pfizer recalls all Chantix lots nationwide over concerns of cancer-causing impurity
Fierce Pharma
Thu, 09/16/21 - 10:39 pm
Tags:
Pfizer, Chantix, recalls
Ahead of FDA adcomm, Pfizer, Moderna say COVID jab efficacy dips
Pharmaforum
Thu, 09/16/21 - 11:07 am
Tags:
Pfizer, Moderna, vaccines, FDA, COVID-19, boosters
Pfizer's mRNA flu vaccine candidate set to enter clinic
Biopharma Reporter
Thu, 09/16/21 - 10:54 am
Tags:
Pfizer, MRNA, vaccines, Flu, flu vaccines
Pfizer backs a small Swiss upstart's attempt to discover a non-viral gene therapy
Endpoints
Thu, 09/16/21 - 10:48 am
Tags:
gene therapy, Switzerland, Pfizer, venture capital, funding, Anjarium Biosciences
As Pfizer's booster AdComm nears, FDA staffers say COVID vaccines are already working as intended
Fierce Pharma
Wed, 09/15/21 - 10:33 pm
Tags:
FDA, Pfizer, vaccines, COVID-19, boosters, advisory panels
Pfizer and Trillium: How a $25M investment led to a $2.3B buyout
Fierce Biotech
Tue, 09/14/21 - 10:52 am
Tags:
Pfizer, Trillium Therapeutics, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.